Follow-The-Filings

Security

Capricor Therapeutics Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners max 0.0% (Steve Cohen - Point72 Ass...)

owners 9
max % 0.0%
tracked value $142M
qoq A 2 R 5

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce -0.03 pp 821,179 $25M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 297,123 $9M hist
Farallon Capital Management LLC 2026 Q1 0.0% 41,000 $1M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,561,880 $74M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 539,232 $16M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 356,354 $11M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 109,531 $3M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 54,773 $2M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 10,022 $305 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $25.18M $22.27M $0.00
Gross profit
Gross margin
Net income -$22.29M -$40.47M -$105.04M
Net margin * -88.5% -181.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $50.86M $163.39M $322.94M
Total non-current assets * $7.88M $7.1M $33.01M
Total assets $58.73M $170.48M $355.95M
Total current liabilities $31.27M $21.03M $35.84M
Total non-current liabilities $4.86M $3.99M $14.32M
Total equity $22.6M $145.46M $305.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$25.6M -$40M -$69.81M
Cash from investing $5.11M -$116.18M $97.48M
Cash from financing $25.58M $152.77M $248.89M
Net change in cash * $5.09M -$3.41M $276.56M

ownership over time

filing count by report period · click a bar for that quarter’s holders